PL131162B1 - Process for preparing novel derivatives of 4h-pyrido /1,2-a/ pyrimidin-4-one - Google Patents

Process for preparing novel derivatives of 4h-pyrido /1,2-a/ pyrimidin-4-one Download PDF

Info

Publication number
PL131162B1
PL131162B1 PL1981233902A PL23390281A PL131162B1 PL 131162 B1 PL131162 B1 PL 131162B1 PL 1981233902 A PL1981233902 A PL 1981233902A PL 23390281 A PL23390281 A PL 23390281A PL 131162 B1 PL131162 B1 PL 131162B1
Authority
PL
Poland
Prior art keywords
formula
alk
group
pyrido
hydrogen atom
Prior art date
Application number
PL1981233902A
Other languages
English (en)
Polish (pl)
Other versions
PL233902A1 (da
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL233902A1 publication Critical patent/PL233902A1/xx
Publication of PL131162B1 publication Critical patent/PL131162B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL1981233902A 1980-03-28 1981-03-27 Process for preparing novel derivatives of 4h-pyrido /1,2-a/ pyrimidin-4-one PL131162B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13484580A 1980-03-28 1980-03-28

Publications (2)

Publication Number Publication Date
PL233902A1 PL233902A1 (da) 1982-07-19
PL131162B1 true PL131162B1 (en) 1984-10-31

Family

ID=22465278

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1981230364A PL132428B1 (en) 1980-03-28 1981-03-27 Proces for preparing novel derivatives of 3-/1-piperidinalkyl/-nh-pyrido-/1,2-a/-pyrimidin-4-one
PL1981233902A PL131162B1 (en) 1980-03-28 1981-03-27 Process for preparing novel derivatives of 4h-pyrido /1,2-a/ pyrimidin-4-one

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL1981230364A PL132428B1 (en) 1980-03-28 1981-03-27 Proces for preparing novel derivatives of 3-/1-piperidinalkyl/-nh-pyrido-/1,2-a/-pyrimidin-4-one

Country Status (5)

Country Link
JP (1) JPS56150091A (da)
KR (2) KR850000412B1 (da)
PL (2) PL132428B1 (da)
SU (1) SU1093251A3 (da)
ZA (1) ZA812085B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0615529B2 (ja) * 1985-04-01 1994-03-02 エーザイ株式会社 新規ピペリジン誘導体
EP0335442B1 (en) * 1988-03-28 1996-05-15 Janssen Pharmaceutica N.V. Agents for preserving or restoring the soundness of the skin
WO2009108798A1 (en) 2008-02-29 2009-09-03 Vm Discovery Inc. Method for treating pain syndrome and other disorders
ES2697174T3 (es) 2012-02-10 2019-01-22 Ptc Therapeutics Inc Compuestos para tratar atrofia muscular espinal
WO2016196386A1 (en) 2015-05-30 2016-12-08 Ptc Therapeutics, Inc. Methods for modulating rna splicing
DK3386511T3 (da) 2015-12-10 2021-07-05 Ptc Therapeutics Inc Fremgangsmåder til behandling af huntingtons sygdom
JP2019535789A (ja) 2016-11-28 2019-12-12 ピーティーシー セラピューティクス，インコーポレーテッド Ｒｎａスプライシングを調節する方法
EP3634953B1 (en) 2017-06-05 2024-01-03 PTC Therapeutics, Inc. Compounds for treating huntington's disease
EA202090034A1 (ru) 2017-06-14 2020-04-16 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способы модификации сплайсинга рнк
WO2019005980A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. METHODS OF TREATING HUNTINGTON'S DISEASE
EP3645121A4 (en) 2017-06-28 2021-03-17 PTC Therapeutics, Inc. HUNTINGTON'S DISEASE TREATMENT METHODS
BR112020019373A2 (pt) 2018-03-27 2020-12-29 Ptc Therapeutics, Inc. Compostos para o tratamento da doença de hutington
AU2019294478B2 (en) 2018-06-27 2023-03-23 Ptc Therapeutics, Inc. Heterocyclic and heteroaryl compounds for treating Huntington's disease
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease

Also Published As

Publication number Publication date
ZA812085B (en) 1982-11-24
PL132428B1 (en) 1985-03-30
JPH0215550B2 (da) 1990-04-12
SU1093251A3 (ru) 1984-05-15
KR850000413B1 (ko) 1985-03-26
PL230364A1 (da) 1982-03-29
KR830005220A (ko) 1983-08-03
JPS56150091A (en) 1981-11-20
PL233902A1 (da) 1982-07-19
KR850000412B1 (ko) 1985-03-26

Similar Documents

Publication Publication Date Title
EP0236930B1 (en) Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2h)one-1,1-dioxide derivatives
PL131162B1 (en) Process for preparing novel derivatives of 4h-pyrido /1,2-a/ pyrimidin-4-one
SK31793A3 (en) Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines and piperazines and compositions and methods of use thereof
EP0086422B1 (en) Pharmacologically active pyrazolo(4,3-c)pyridines
CS256366B2 (en) Method of new 3-(1-piperidinylalkyl)-4h-pyridol(1,2-pyrimidine-4-on derivatives production
HU201553B (en) Process for producing tetrahydrofuro- and -thieno(2,3-c)pyridines and pharmaceutical compositions comprising same
CS196290B2 (en) Process for preparing new compounds
US4636563A (en) Antipsychotic γ-carbolines
Abou-Gharbia et al. Antipsychotic activity of substituted. gamma.-carbolines
US4138494A (en) 3-Phenylindolines
US4672117A (en) Antipsychotic gamma-carbolines
Cain et al. Potential antitumor agents. 19. Multiply substituted 4'-(9-acridinylamino) methanesulfonanilides
US4663456A (en) 2-(substituted piperazinylalkyl)β-carbolines useful in treatment of psychological disorders
Cain et al. Potential antitumor agents. 20. Structure-activity-site relations for the 4'-(9-acridinylamino) alkanesulfonanilides
JPH0686435B2 (ja) ベンズアゼピン誘導体
FI73674B (fi) Foerfarande och mellanprodukt foer framstaellning av farmakologiskt vaerdefulla 1-fenylindazol-3-on-foereningar.
US4012373A (en) Pyrazolo[3',4'-2,3]pyrido[4,5-e]b-benzo-1,5-diazepinones
JPS61254585A (ja) 三環式誘導体
JPS60158190A (ja) ヒダントイン誘導体およびその製法ならびにそれを含有する医薬
EP0025603B1 (en) Triazolo (4,3-a)pyridin-3(2h)-ones, process for their preparation and pharmaceutical compositions containing them
US4789676A (en) Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives, usefull as anxiolytic agents
US3654290A (en) Intermediates for 5-(pyridylalkyl) pyridoindole derivatives
JPH02233682A (ja) ８，９―アヌレーション化―１，２，３，４―テトラヒドロ―β―カルボリン誘導体
US4920118A (en) Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3-(2H)one-1,1-dioxide and their use as anxiolytic and anti-hypertensive agents
JPH03148284A (ja) ジヒドロピリミドチアジン誘導体、それを主成分とする抗炎症剤等製剤組成物、その製造の際の中間体、およびそれらの製造方法